⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 1, 2024Drug Design Development and TherapyOpen Access

Integrating Network Pharmacology and Experimental Validation to Investigate the Mechanism of Qushi Huatan Decoction Against Coronary Heart Disease

Chunxia Yin Tao-Hua Lan Yunshan Wu Jing Cai Haoxiang Li Xiaolan Kuang Lin Jiao Xiaomin Ou Hua Yang Bo Liu Weihui Lu

View Full Paper

Ask AI

Bookmark

Share

Abstract

This study was designed to evaluate the effect and mechanism of the Qushi Huatan (QSHT) decoction against coronary heart disease (CHD) through network pharmacology and experimental verification.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yin et al. (2024) studied this question.

synapsesocial.com/papers/68e59d88b6db643587537eb0 https://doi.org/10.2147/dddt.s463054

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathwaypreclinical · 2024 · 15 citations
2Mechanism of Baihe Decoction in the treatment of coronary heart disease based on network pharmacology and molecular dockingpreclinical · 2021 · 13 citations
3Integrated metabolomics and network pharmacology leveraging UPLC-Q-TOF-MS reveal material basis and metabolic mechanisms underlying Tongqiao Huoxue Decoction's efficacy in cerebral infarction.Randomized Controlled Trial · 2026
4Elucidating the therapeutic mechanisms of Huatan Qushi decoction in reducing obesity: Insights from a high-fat diet mouse modelOriginal Research · 2026
5Exploring the mechanism of Yi Qi Huo Xue compound prescription in treating chronic heart failure based on integrated network pharmacology and transcriptomicspreclinical · 2026

More related papers

Exploring the effective compounds and potential mechanisms of Shengxian Decoction against coronary heart disease by UPLC-Q-TOF/MS and network pharmacology analysis2024
Integrative Approaches to Uncover the Therapeutic Action of Huaiqihuang in Myocarditis: Network Pharmacology, Molecular Docking, and Molecular Dynamics.2026
Network Pharmacology Analysis and Experimental Validation Reveal the Mechanism of Action of Longlutong Decoction in the Treatment ofCoronary Heart Disease2025

More from Drug Design Development and Therapy

External Validation and Bayesian Forecasting of Rivaroxaban Population Pharmacokinetic Models in Older Chinese Patients with Nonvalvular Atrial FibrillationTue,
The Role of Thrombospondin-2 in Myocardial FibrosisTue,